Once a decision has been made to prescribe OPSYNVI®

J&J withMe offers resources and education for access, affordability, and treatment support

Access support to help navigate payer processes by verifying insurance coverage, requirements for approval, and providing reimbursement information
Affordability support to help your patients find out what affordability options may be available
Treatment support, including PAH Companion withMe, to help your patients get informed and stay on the J&J treatment you prescribe

Therapy Access Managers

Educate on payer-specific policies for approval
Monitor and triage potential patient access issues

J&J withMe Care Coordinators

Conduct benefits investigations
Help find cost support options for eligible patients

Need additional help or information?

Call a J&J withMe Care Coordinator at 866-228-3546, Monday–Friday, 8:00 AM–8:00 PM ET or visit JNJwithMe.com.

JNJwithMe.com

The patient support and resources provided by J&J withMe are not intended to provide medical advice, replace a treatment plan from the patient’s doctor or nurse, provide case management services, or serve as a reason to prescribe a J&J Medicine.

Treatment support to help your patients start on their prescribed medicine

Dual Voucher Offering for OPSYNVI® and OPSUMIT®

Free trial offers are available for OPSYNVI® (macitentan/tadalafil) and OPSUMIT® (macitentan) to help patients become familiar with OPSUMIT® first and then OPSYNVI®.

At the conclusion of the trial, you and your patient decide whether to continue treatment. Subject to one (1) use per lifetime for the patient’s first trial of OPSYNVI® and/or OPSUMIT®. Terms for both programs expire at the end of each calendar year and may change. These Voucher Programs are open to patients who have commercial insurance, government coverage, or no insurance coverage; however, there is no guarantee of continuous accessibility after the program ends.

See program requirements at

JNJwithMe.com/Opsynvi-Voucher

and

JNJwithMe.com/Opsumit-Voucher

Evaluate efficacy and safety for up to 90 days

30DAYS

10 mg/20 mg

DAYS

if tolerated after 7 days, titrate up

10 mg/40 mg

30DAYS

Support for patients using commercial or private insurance to pay for medicine

J&J withMe Oral PAH Savings Program

Your eligible patients will pay $5 per prescription fill. Maximum program benefit per calendar year shall apply across all oral PAH therapies in the program. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medicines. Terms expire at the end of each calendar year. Offer subject to change or end without notice. Restrictions, including monthly maximums, may apply. Patients may participate without sharing their income information. See program requirements at

OPSYNVI.JNJwithMeSavings.com.

RESOURCES

Downloadable Resources for OPSYNVI®

OPSYNVI® Patient Brochure

This brochure for patients provides a background on OPSYNVI® and what can be expected when starting treatment.

Call 1-800-526-7736

for product-related medical inquiries

Or connect via email